![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
GIFT-I: ALT CHANGES WITH OMBITASVIR/PARITAPREVIR/RITONAVIR
AND CONCOMITANT USE OF HEPATOPROTECTIVES
|
|
|
Reported by Jules Levin
The 25th Conference of the Asian Pacific Association for the Study of the Liver ⋅ Tokyo, Japan ⋅ 20-24 February 2016
Hidenori Toyoda, Kazuaki Chayama, Lino Rodrigues-Jr, Kenji Ikeda, Fumitaka Suzuki, Ken Sato, Yoshiyasu Karino, Yasushi Matsuzaki, Kiyohide Kioka, Xinyan Zhang, Margaret H. Burroughs, Hiromitsu Kumada
![APASL1](../images/022216/022216-12/APASL1.gif)
![APASL2](../images/022216/022216-12/APASL2.gif)
![APASL3](../images/022216/022216-12/APASL3.gif)
![APASL4](../images/022216/022216-12/APASL4.gif)
![APASL5](../images/022216/022216-12/APASL5.gif)
![APASL6](../images/022216/022216-12/APASL6.gif)
![APASL7](../images/022216/022216-12/APASL7.gif)
![APASL8](../images/022216/022216-12/APASL8.gif)
![APASL9](../images/022216/022216-12/APASL9.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|